Skip to main content

Table 1 Baseline characteristics at enrollment of subjects who completed all 3 arms of the study

From: Differential effects of hydrocortisone, prednisone, and dexamethasone on hormonal and pharmacokinetic profiles: a pilot study in children with congenital adrenal hyperplasia

Number of subjects

9 (5 female)

Glucocorticoid regimen prior to entering the study

Hydrocortisone (7), prednisone (2)

Dose of hydrocortisone (mg/m2/day) equivalent

15.6 ± 4.0

Age (years)

8.1 ± 2.3

Bone age (years)

8.6 ± 2.9

Height (cm); z-score

127.6 ± 17.9; 0.0 ± 1.2

Weight (kg); z-score

39.1 ± 24.0; 1.0 ± 1.4

BMI (kg/m2); z-score

22.0 ± 8.1; 1.2 ± 1.1

17-hydroxyprogesterone (ng/dL)

991.1 ± 978.5

89.4 (0.4–2500.0)

Androstenedione (ng/dL)

35.2 ± 22.5

22.3 (2.0–392.0)

  1. Values are mean ± standard deviation, with 17-hydroxyprogesterone and androstenedione also including median (minimum – maximum) due to data skewness